Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Cell Science

• Publication date

  2010-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1242/jcs.061002PMID 20332115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ductal Carcinoma In Situ of the Breast

  2012cited by this paper
• p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

  2009cited by this paper
• EMT, the cytoskeleton, and cancer cell invasion

  2009cited by this paper
• p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

  2009cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility

  2007cited by this paper
• Loss of p53 promotes RhoA–ROCK-dependent cell migration and invasion in 3D matrices

  2007influential reference
• Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome

  2007cited by this paper
• p53: a two-faced cancer gene

  2007cited by this paper
• Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

  2006cited by this paper
• Control of cell migration: a tumour suppressor function for p53?

  2006cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006cited by this paper
• Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.

  2005cited by this paper
• Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

  2004cited by this paper
• Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion

  2004cited by this paper
• DNA damage checkpoint kinase Chk2 triggers replicative senescence

  2004cited by this paper
• Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Transcriptional regulation of cadherins during development and carcinogenesis.

  2004cited by this paper
• Decision making by p53: life, death and cancer

  2003cited by this paper
• Relationship between E‐cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl‐2 expression and Ki‐67 staining in diffuse‐type gastric carcinoma

  2003cited by this paper
• Metastasis genes: A progression puzzle

  2002cited by this paper
• The SLUG zinc-finger protein represses E-cadherin in breast cancer.

  2002cited by this paper
• A progression puzzle.

  2002cited by this paper
• Inactivation of p21 WAF1 Sensitizes Cells to Apoptosis via an Increase of Both p14ARF and p53 Levels and an Alteration of the Bax/Bcl-2 Ratio*

  2002cited by this paper
• Live or let die: the cell's response to p53

  2002cited by this paper
• Regulation of Cdc42‐mediated morphological effects: a novel function for p53

  2002cited by this paper
• p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.

  2001cited by this paper
• Assessing TP53 status in human tumours to evaluate clinical outcome

  2001cited by this paper
• Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I

  2001cited by this paper
• Redox signalling and transition metals in the control of the p53 pathway.

  2000cited by this paper
• Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

  2000cited by this paper
• The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

  2000cited by this paper
• p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.

  1999cited by this paper
• Regulation of p53 stability

  1999cited by this paper
• Regulation of metastasis‐related gene expression by p53: A potential clinical implication

  1999cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• E-cadherin germline mutations in familial gastric cancer

  1998cited by this paper
• A causal role for E-cadherin in the transition from adenoma to carcinoma

  1998cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• ZEB, a vertebrate homolog of Drosophila Zfh‐1, is a negative regulator of muscle differentiation

  1997cited by this paper
• Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

  1995cited by this paper
• Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.

  1994cited by this paper
• WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

  1994cited by this paper
• Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

  1994cited by this paper
• Analysis of the most representative tumour‐derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

  1994cited by this paper
• A temperature‐sensitive mutant of human p53.

  1994cited by this paper
• Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

  1991cited by this paper
• Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

  1990cited by this paper
• A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40.

  1987cited by this paper
• Loss of p 53 promotes RhoA – ROCK-dependent cell migration and invasion in 3 D matrices

  year unknowninfluential reference

• P53 Inhibition Diminishes IGSF9 Gene Activity to Promote DNA Repair and Exacerbate the Progression of Colon Cancer

  2026cites this paper
• Mutant p53: evolving perspectives

  2025cites this paper
• Gain of function p53 mutant R273H confers distinct methylation profiles and consequent YAP/TAZ signaling mediated activation of partial or full EMT states to colon tumours

  2025cites this paper
• Role of EMT in drug resistance of breast cancer: molecular mechanisms and therapeutic strategies

  2025cites this paper
• Correlations of Protein 53 (p53) Expression with the Degree of Tumor Budding in Cervical Carcinoma

  2025cites this paper
• Targeting the MCM10/p53/p21/CCND1 Axis in Colorectal Cancer: Evaluating the Therapeutic Potential of Ultrasound.

  2025cites this paper
• The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination

  2025influential citation
• Preclinical and Molecular Docking Insights into the Chemopreventive Role of Fenugreek Seed Extract in a Murine Model of Colorectal Cancer

  2025cites this paper
• Resveratrol and p53: How are they involved in CRC plasticity and apoptosis?

  2024cites this paper
• Bestrophin-4 relays HES4 and interacts with TWIST1 to suppress epithelial-to-mesenchymal transition in colorectal cancer cells

  2024cites this paper
• Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3

  2024cites this paper
• Breast carcinogenesis induced by organophosphorous pesticides.

  2023cites this paper
• CircFSCN1 induces tumor progression and triggers epithelial-mesenchymal transition in bladder cancer through augmentation of MDM2-mediated p53 silencing.

  2023cites this paper
• Mutant p53 and ELK1 co‐drive FRA‐1 expression to induce metastasis in breast cancer

  2023cites this paper
• microRNA-205 represses breast cancer metastasis by perturbing the rab coupling protein [RCP]-mediated integrin β1 recycling on the membrane

  2023cites this paper
• A comprehensive prognostic score for head and neck squamous cancer driver genes and phenotype traits

  2023cites this paper
• Crosstalk between long non-coding RNAs and p53 signaling pathway in colorectal cancer: A review study.

  2023cites this paper
• 2-(4-Benzyloxy-3-methoxyphenyl)-5-(carbethoxyethylene)-7-methoxy-benzofuran, a Benzofuran Derivative, Suppresses Metastasis Effects in P53-Mutant Hepatocellular Carcinoma Cells

  2023cites this paper
• Rectal Carcinoma With a Sarcomatoid Component: A Case Report With Detailed Immunohistochemistry, Molecular Analysis, and Literature Review

  2023cites this paper
• The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update.

  2023cites this paper
• Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway

  2022cites this paper
• Should mutant TP53 be targeted for cancer therapy?

  2022cites this paper
• PRP4 Induces Epithelial–Mesenchymal Transition and Drug Resistance in Colon Cancer Cells via Activation of p53

  2022cites this paper
• Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.

  2022cites this paper
• Decoding Single Cell Morphology in Osteotropic Breast Cancer Cells for Dissecting Their Migratory, Molecular and Biophysical Heterogeneity

  2022cites this paper
• Type 2 human papillomavirus E7 attenuates E-cadherin expression in human keratinocytes

  2021cites this paper
• p66α Suppresses Breast Cancer Cell Growth and Migration by Acting as Co-Activator of p53

  2021cites this paper
• Targeting mutant p53 for cancer therapy: direct and indirect strategies

  2021cites this paper
• Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells

  2021cites this paper
• Differentiated pre-adipocytes promote proliferation, migration and epithelial-mesenchymal transition in breast cancer cells of different p53 status

  2021cites this paper
• USP42 protects ZNRF3/RNF43 from R‐spondin‐dependent clearance and inhibits Wnt signalling

  2021cites this paper
• Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets

  2020cites this paper
• Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications

  2020cites this paper
• TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection

  2020cites this paper
• Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.

  2020cites this paper
• Elevated Expression of LYPD3 Is Associated with Lung Adenocarcinoma Carcinogenesis and Poor Prognosis

  2020cites this paper
• Mutant p53 on the Path to Metastasis.

  2020cites this paper
• CHCHD4 regulates tumour proliferation and EMT-related phenotypes, through respiratory chain-mediated metabolism

  2019cites this paper
• Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53

  2019cites this paper
• The tumor suppressor p53 can promote collective cellular migration

  2019cites this paper
• Fibroblast growth factor-10 and epithelial-mesenchymal transition in colorectal cancer

  2019cites this paper
• X-linked inhibitor of apoptosis protein accelerates migration by inducing epithelial–mesenchymal transition through TGF-β signaling pathway in esophageal cancer cells

  2019cites this paper
• CHCHD4 regulates a proliferation-EMT switch in tumour cells, through respiratory complex I mediated metabolism

  2019cites this paper
• p53-Autophagy-Metastasis Link

  2018cites this paper
• p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations

  2018cites this paper
• Probable hereditary familial overlap syndrome with multiple synchronous lung tumors.

  2018cites this paper
• Mutant p53 in cancer therapy—the barrier or the path

  2018cites this paper
• Mutant p53 hinges between epithelial-mesenchymal transition and cancer stem cells

  2018cites this paper
• The tumor suppressor p53 promotes carcinoma invasion and collective cellular migration

  2018cites this paper
• Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity

  2018cites this paper
• In vivo stem cell tracking with imageable nanoparticles that bind bioorthogonal chemical receptors on the stem cell surface.

  2017cites this paper
• TP 53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients

  2017cites this paper
• Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function

  2017cites this paper
• Endocrine therapy inhibits proliferation and migration, promotes apoptosis and suppresses survivin protein expression in colorectal cancer cells

  2017cites this paper
• Regulation of autophagy and EMT by the interplay between p53 and RAS during cancer progression (Review).

  2017cites this paper
• A truncated p53 in human lung cancer cells as a critical determinant of proliferation and invasiveness

  2017cites this paper
• miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines

  2017cites this paper
• The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells

  2017cites this paper
• TP53 drives invasion through expression of its 133p53 variant

  2016influential citation
• Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.

  2016cites this paper
• TP53 drives invasion through expression of its Δ133p53β variant

  2016influential citation
• Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro

  2016cites this paper
• Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression.

  2016cites this paper
• Mitochondrial Stress Induced p53 Attenuates HIF-1α Activity by Physical Association and Enhanced Ubiquitination

  2016cites this paper
• New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer

  2016cites this paper
• Epithelial-mesenchymal transition and drug resistance in breast cancer (Review).

  2015cites this paper
• Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.

  2015cites this paper
• Zn(II)-curc targets p53 in thyroid cancer cells

  2015cites this paper
• The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential

  2015cites this paper
• Zn(II)-curc targets p53 in thyroid cancer cells

  2015cites this paper
• Mutant p53 promotes epithelial‐mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP‐T mice

  2015cites this paper
• Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer.

  2014cites this paper
• The Curses and the Blesses of E-Cadherin

  2014cites this paper
• Bringing p53 into the Clinic

  2014cites this paper
• The role of the proline rich homeodomain in the regulation of proliferation, survival and migration of breast cells

  2014cites this paper
• TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients

  2014cites this paper
• Discovery of a p53 variant that controls metastasis

  2014cites this paper
• Overexpression of Snail in retinal pigment epithelial triggered epithelial-mesenchymal transition.

  2014cites this paper
• Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.

  2014cites this paper
• 肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义

  2014cites this paper
• Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

  2014cites this paper
• Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells

  2014cites this paper
• Herbimycin A inhibits cell growth with reversal of epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells.

  2014cites this paper
• FGFR3 has tumor suppressor properties in cells with epithelial phenotype

  2013cites this paper
• p53 regulates epithelial–mesenchymal transition induced by transforming growth factor β

  2013cites this paper
• Decoding the knots of initiation of oncogenic epithelial-mesenchymal transition in tumor progression.

  2013cites this paper
• Mutant p53 in cell adhesion and motility.

  2013cites this paper
• Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4

  2013cites this paper
• High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H

  2013cites this paper
• The role of SLIRP and Notch signalling in colorectal cancer

  2013cites this paper
• Slug Expression in Mouse Skin and Skin Tumors Is Not Regulated by p53

  2013cites this paper
• Plakophilin3 Loss Leads to an Increase in PRL3 Levels Promoting K8 Dephosphorylation, Which Is Required for Transformation and Metastasis

  2012cites this paper
• Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression

  2012cites this paper
• Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model.

  2012cites this paper
• Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition

  2012cites this paper
• Clinicopathological features of stomach cancer with invasive micropapillary component

  2012cites this paper
• Loss of E-cadherin in multidrug resistant breast cancer cell line MCF-7/Adr: possible implication in the enhanced invasive ability.

  2012cites this paper
• Clinicopathological features of stomach cancer with invasive micropapillary component

  2012cites this paper
• The rebel angel: mutant p53 as the driving oncogene in breast cancer

  2012cites this paper
• Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6

  2012cites this paper